INS and Hepatic steatosis: IL-17 is one of the central molecules of the Th17/IL-23 axis that interferes with hepatic steatosis in nonalcoholic fatty liver disease (NAFLD), and insulin signalling and IL-17R expression correlate with insulin resistance [16,17].